Evidence has accumulated in the recent years further corroborating an immune-mediated
process underlying aplastic anemia pathogenesis. Hematopoietic stem-cell transplantation …

This review highlights some of the contributions that have appeared in the literature in the
past decade on the pathogenesis and treatment of aplastic anemia (AA). This summary is …

We analyzed the outcome of 537 adolescents (age 12–18 years) with idiopathic aplastic
anemia included in the database of the Severe Aplastic Anemia Working Party of the …

Newly diagnosed aplastic anemia is a serious condition, with more than 75%(higher in
young patients) becoming long-term survivors if diagnosed and treated appropriately. First …

Acquired aplastic anemia is a potentially fatal bone marrow failure disorder that is
characterized by pancytopenia and a hypocellular bone marrow. Hematopoietic stem-cell …

Opinion statement Acquired aplastic anemia (AA) is a rare, life-threatening bone marrow
failure (BMF) disorder that affects patients of all ages and is caused by lymphocyte …

Aplastic anemia is a rare disorder characterized by suppression of bone marrow function
resulting in progressive pancytopenia. A trigger-related abnormal T cell response facilitated …

Abstract Background and Objectives The treatment of acquired aplastic anemia (AA) is
based on allogeneic bone marrow transplantation (BMT) and immunosuppressive therapy …

Aplastic anemia, an unusual hematologic disease, is the paradigm of the human bone
marrow failure syndromes. Almost universally fatal just a few decades ago, aplastic anemia …

Acquired aplastic anemia (AA) is a rare heterogeneous disease characterized by
pancytopenia and hypoplastic bone marrow. The incidence is 2–3/million inhabitants/year …